SPDR S&P Biotech ETF (XBI) Holdings Raised by Financial Advantage Inc.

Financial Advantage Inc. raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 15,383 shares of the exchange traded fund’s stock after acquiring an additional 1,340 shares during the quarter. SPDR S&P Biotech ETF accounts for about 1.1% of Financial Advantage Inc.’s holdings, making the stock its 24th biggest position. Financial Advantage Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,475,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the business. Rockefeller Capital Management L.P. acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $130,000. WP Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $133,000. Trust Co. of Vermont acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $136,000. Squar Milner Financial Services LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $139,000. Finally, Valeo Financial Advisors LLC raised its stake in shares of SPDR S&P Biotech ETF by 165.2% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,525 shares of the exchange traded fund’s stock worth $144,000 after buying an additional 950 shares during the last quarter.

NYSEARCA:XBI opened at $79.11 on Thursday. SPDR S&P Biotech ETF has a 52-week low of $76.37 and a 52-week high of $101.55.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also: Return on Investment (ROI)

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply